These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3133011)

  • 1. Chemotherapy for carcinoma in situ of the bladder.
    Jenkins BJ; England HR; Fowler CG; Tiptaft RC; Badenoch DF; Paris AM; Oliver RT; Blandy JP
    Br J Urol; 1988 Apr; 61(4):326-9. PubMed ID: 3133011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer. Finnbladder Research Group.
    Rintala E; Jauhiainen K; Alfthan O
    Prog Clin Biol Res; 1989; 310():271-4. PubMed ID: 2505270
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical mitomycin C for carcinoma in situ of the urinary bladder.
    Hellsten S; Månsson W; Henrikson H; Idwall I; Lindholm K; Mikulowski P; Mårtensson S; Oldbring J
    Scand J Urol Nephrol; 1990; 24(1):35-8. PubMed ID: 2108491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.
    Giesbers AA; Van Helsdingen PJ; Kramer AE
    Br J Urol; 1989 Feb; 63(2):176-9. PubMed ID: 2495144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical mitomycin C therapy for carcinoma in situ of the bladder: a followup.
    Stricker PD; Grant AB; Hosken BM; Taylor JS
    J Urol; 1990 Jan; 143(1):34-5; discussion 35-6. PubMed ID: 2104637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical chemotherapy for carcinoma in situ of the urinary bladder: 5 years later.
    Jakse G
    Eur Urol; 1984; 10(5):289-93. PubMed ID: 6440791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical mitomycin C and superficial bladder tumors.
    Biserte J; Rigot JM; Mauroy B; Mazeman E
    Prog Clin Biol Res; 1989; 303():411-5. PubMed ID: 2506555
    [No Abstract]   [Full Text] [Related]  

  • 10. BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale and design of the trial of the Southeast Co-operative Urological Group, The Netherlands.
    van der Meijden PM; Debruyne FM; Steerenberg PA; de Jong WH; Doesburg W
    Prog Clin Biol Res; 1989; 310():285-98. PubMed ID: 2505272
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravesical combination chemotherapy with mitomycin C and doxorubicin for carcinoma in situ of the bladder.
    Fukui I; Sekine H; Kihara K; Yamada T; Takeuchi S; Yokokawa M; Kawai T; Hosoda K; Ohwada F; Suzuki S
    J Urol; 1989 Mar; 141(3):531-4. PubMed ID: 2493099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical mitomycin C therapy for carcinoma of the bladder.
    Stricker PD; Grant AB; Hosken BM; Taylor JS
    J Urol; 1987 Nov; 138(5):1164-6. PubMed ID: 3118056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystectomy: the treatment of choice in patients with carcinoma in situ of the urinary bladder?
    Jakse G; Putz A; Feichtinger J
    Eur J Surg Oncol; 1989 Jun; 15(3):211-6. PubMed ID: 2737308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of superficial G2 (pTa and pT1) bladder cancer.
    Thorpe AC; Jenkins BJ; Martin JE
    Urology; 1990 Nov; 36(5):395-7. PubMed ID: 2238296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive intravesical chemotherapy in the treatment of flat carcinoma in situ: is it safe?
    Droller MJ; Walsh PC
    J Urol; 1985 Dec; 134(6):1115-7. PubMed ID: 3932686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sequential instillation therapy with mitomycin-C and adriamycin in superficial bladder tumor with special reference to fate of 43 patients achieving complete response].
    Fukui I; Sekine H; Kihara K; Yamada T; Kawai T; Washizuka M; Ishiwata D; Oka K; Hosoda K; Ikegami S
    Nihon Hinyokika Gakkai Zasshi; 1987 Sep; 78(9):1539-44. PubMed ID: 3127621
    [No Abstract]   [Full Text] [Related]  

  • 17. Carcinoma in situ associated with superficial bladder tumor.
    Solsona E; Iborra I; Ricós JV; Monrós JL; Dumont R; Casanova J; Calabuig C
    Eur Urol; 1991; 19(2):93-6. PubMed ID: 1902418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guérin for carcinoma in situ of the bladder.
    Merz VW; Marth D; Kraft R; Ackermann DK; Zingg EJ; Studer UE
    Br J Urol; 1995 Feb; 75(2):180-4. PubMed ID: 7850322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitomycin C in superficial bladder cancer: 24-month follow-up.
    Somerville JJ; Newling DW; Richards B; Robinson MR; Smith PH
    Br J Urol; 1985 Dec; 57(6):686-9. PubMed ID: 3936564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of superficial bladder cancer with intravesical mitomycin C: analysis of immediate and long-term response in 70 patients.
    Soloway MS
    J Urol; 1985 Dec; 134(6):1107-9. PubMed ID: 3932684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.